What is the Projected CAGR value of the Gastroparesis Drugs Market ?
Gastroparesis Drugs Market is expected to grow at a high CAGR during the forecast period 2024-2031
Who are the key players in Gastroparesis Drugs Market ?
Major players are Abbott Laboratories, AstraZeneca Plc, Cadila Pharmaceuticals Ltd, ETX Pharma, Inc, Evoke Pharma, GlaxoSmithKline Plc, Neurogastrx, Inc, Valeant Pharmaceuticals International, Inc, Theravance Biopharma, Johnson & Johnson and Teva Pharmaceutical Industries.